These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9355875)

  • 1. Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response?
    Hartmann KA; Van der Kleij AJ; Schneider CJ; Sminia P
    Radiat Res; 1997 Nov; 148(5):523-5. PubMed ID: 9355875
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.
    Brizel DM; Hage WD; Dodge RK; Munley MT; Piantadosi CA; Dewhirst MW
    Radiat Res; 1997 Jun; 147(6):715-20. PubMed ID: 9189170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comments on hyperbaric oxygen and carbogen/nicotinamide with fractionated radiation.
    Brown JM; Wouters BG
    Radiat Res; 1997 Nov; 148(5):526-7. PubMed ID: 9355876
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ; Saunders MI; Dische S
    Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbogen and nicotinamide: expectations too high?
    Brown JM
    Radiother Oncol; 1992 Jun; 24(2):75-6. PubMed ID: 1386679
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbogen and nicotinamide: expectations too high? (response to J. Martin Brown).
    Horsman MR
    Radiother Oncol; 1992 Jun; 24(2):121-2. PubMed ID: 1386677
    [No Abstract]   [Full Text] [Related]  

  • 7. Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy.
    Rojas A; Joiner MC; Denekamp J
    Radiother Oncol; 1992 Jun; 24(2):123-4. PubMed ID: 1386678
    [No Abstract]   [Full Text] [Related]  

  • 8. ARCON.
    Rojas A
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():34-5. PubMed ID: 8946047
    [No Abstract]   [Full Text] [Related]  

  • 9. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
    Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
    Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
    Horsman MR; Siemann DW; Nordsmark M; Khalil AA; Overgaard J; Chaplin DJ
    Adv Exp Med Biol; 1994; 361():635-42. PubMed ID: 7597993
    [No Abstract]   [Full Text] [Related]  

  • 13. The potential for improving radiotherapy outcome by improving the oxygen supply to solid tumours.
    Denekamp J; Waites A
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():22-3. PubMed ID: 8946041
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.
    Hoskin PJ; Rojas AM; Bentzen SM; Saunders MI
    J Clin Oncol; 2010 Nov; 28(33):4912-8. PubMed ID: 20956620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A; Menke D; Dorie MJ; Brown JM
    Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early skin response to fractionated doses of pions for determining therapeutic gain factors.
    Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
    Tokai J Exp Clin Med; 1996 Jun; 21(2):69-75. PubMed ID: 9239808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen and nicotinamide.
    Droller MJ
    J Urol; 2000 May; 163(5):1600. PubMed ID: 10798919
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of fractionated irradiation with nicotinamide and carbogen in R1H-tumours of the rat and its pulmonary metastases.
    Raabe A; Rett M; Krüll A; Beck-Bornholdt HP
    Radiother Oncol; 1997 Nov; 45(2):183-9. PubMed ID: 9424010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumours.
    Simon JM; Lartigau E; Guichard M
    Radiother Oncol; 1993 Sep; 28(3):203-7. PubMed ID: 8255997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas.
    van der Maazen RW; Thijssen HO; Kaanders JH; de Koster A; Keyser A; Prick MJ; Grotenhuis JA; Wesseling P; van der Kogel AJ
    Radiother Oncol; 1995 May; 35(2):118-22. PubMed ID: 7569019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.